Healthcare Costs and Policy Changes in 2026: A Comprehensive Overview

The start of 2026 witnessed an intensified focus on healthcare, following the conclusion of the longest federal government shutdown in U.S. history. Initially centered on extended Affordable Care Act (ACA) tax credits, discussions have expanded to address broader healthcare costs and alternative payment methods. This shift underscores ongoing issues with healthcare spending and affordability across the nation.

Accounting for approximately 20% of the economy's total expenditures, U.S. healthcare costs are distributed among various payers, including federal and state governments, employers, and individuals. Despite the absence of robust federal cost-containment strategies, policymakers continue to explore measures aimed at reducing individual healthcare costs, focusing on pricing for specific drugs and services.

Healthcare costs in the U.S. continue to rise at a rate exceeding that of peer countries, posing a significant challenge. With the increasing costs of living, healthcare expenses remain a primary concern, particularly for households with employer-sponsored insurance. In 2023, the financial burden on such families was substantial, with premiums and out-of-pocket costs on the rise.

The lapse of enhanced ACA tax credits has led to increased premiums for Marketplace enrollees, affecting enrollment decisions. Over a million fewer individuals enrolled in Marketplace plans in 2026, with the full impact on coverage yet to be determined. As midterm elections loom, healthcare affordability dominates political discussions and policy debates.

U.S. prescription drug costs are a major component of healthcare expenses, with spending nearly double per capita compared to other countries. Although the Inflation Reduction Act allowed Medicare to negotiate certain drug prices, reducing costs for some beneficiaries, the overall disparity persists. Recent initiatives aim to enhance drug affordability, but widespread impact remains limited due to the predominant role of insurance coverage in medication payment.

Reforming prescription benefit managers (PBMs) remains a key legislative priority, with the Consolidated Appropriations Act of 2026 introducing new reporting and payment frameworks. Efforts focus on transparency and equitable pricing, with ongoing initiatives seeking to reduce drug prices through PBM reform.

Employers are grappling with decisions about covering costly drugs, such as GLP-1 agonists for diabetes and weight loss. The high cost leads many to reconsider coverage, exploring varied expense management strategies, including direct-to-consumer markets and innovative solutions aimed at optimizing outcomes and mitigating costs.

Healthcare provider consolidation, aimed at enhancing care continuity and reducing administrative expenses, has inadvertently led to reduced market competition and higher prices. Efforts to improve market competitiveness include federal and state proposals targeting anti-competitive practices and limiting vertical mergers to foster a more balanced healthcare market.

Advancements in artificial intelligence (AI) significantly impact healthcare documentation, easing administrative burdens and enhancing the accuracy of patient visit documentation. While these technologies offer improvements, they also increase billing complexity, prompting payers to adjust policies to address potential cost implications.

Recent Medicaid financing changes pose challenges for states, providers, and beneficiaries, stemming from new community engagement requirements. Strained state budgets and anticipated revenue reductions for providers heighten concerns over uncompensated care costs.

The Rural Health Transformation program allocates substantial funds to mitigate the impact of Medicaid funding cuts on rural areas, with initiatives focusing on telehealth expansion and alternative care delivery models to improve rural healthcare accessibility. States are advancing technological and policy initiatives aligning with federal priorities to combat chronic health conditions, including telehealth enhancement and workforce expansion.

The Peterson Center on Healthcare and KFF continue to monitor and analyze the U.S. healthcare system's performance, emphasizing cost and quality metrics as critical indicators.